Assignee
JIANGSU AOSAIKANG PHARM CO LTD
CN·9 granted patents·1 pending application·0 citations·filing 2017–2023
Top patents by PatentIndex Score
10 records- 0161US10966993B2Pharmaceutical composition comprising a sulfonylurea drug and preparation method thereofJIANGSU AOSAIKANG PHARM CO LTD·Filed 2017·Granted Apr 6, 2021·0 cites·16 claims
- 0261US2025109156A1Indole-containing macrocyclic compounds and uses thereofJIANGSU AOSAIKANG PHARM CO LTD·Filed 2023·Application pending·0 cites
- 0353US10787651B2Bradyrhizobium monooxygenase and use thereof for preparation of chiral sulfoxideJIANGSU AOSAIKANG PHARM CO LTD·Filed 2018·Granted Sep 29, 2020·0 cites·4 claims
- 0452US11078184B2Dexrabeprazole sodium compound and pharmaceutical composition thereofJIANGSU AOSAIKANG PHARM CO LTD·Filed 2018·Granted Aug 3, 2021·0 cites·4 claims
- 0549US12325695B25-(4-pyridyloxy)pyrazole compounds serving as TGF-βR1 kinase inhibitorJIANGSU AOSAIKANG PHARM CO LTD·Filed 2020·Granted Jun 10, 2025·0 cites·19 claims
- 0649US12122780B2Pyrimidinyl group-containing tricyclic compound serving as c-Met inhibitorJIANGSU AOSAIKANG PHARM CO LTD·Filed 2020·Granted Oct 22, 2024·0 cites·17 claims
- 0746US11345900B2Monooxygenase and use in preparation of optically pure sulfoxideJIANGSU AOSAIKANG PHARM CO LTD·Filed 2019·Granted May 31, 2022·0 cites·14 claims
- 0841US11187683B2Dexrazoxane analytical methodJIANGSU AOSAIKANG PHARM CO LTD·Filed 2017·Granted Nov 30, 2021·0 cites·15 claims
- 0941US11001866B2Burkholderia and applications thereofJIANGSU AOSAIKANG PHARM CO LTD·Filed 2017·Granted May 11, 2021·0 cites·13 claims
- 1039US10752652B2Method for preparing a ß-nucleoside compoundJIANGSU AOSAIKANG PHARM CO LTD·Filed 2017·Granted Aug 25, 2020·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when JIANGSU AOSAIKANG PHARM CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →